Puguang Bio is a developer of in vitro medical diagnostic systems. It pioneered the “ortho-contact chemiluminescence resonance energy transfer (CRET)” platform and realized its industrialization. Based on this innovation, Puguang Bio has solved many problems existing in the most advanced magnetic particle chemiluminescence detection platform for immunodetection, and developed a variety of homogeneous chemiluminescence immunoassay products. Recently, Puguang Bio completed the Pre-A round of financing totaling nearly 100 million yuan. This round of financing was jointly led by Nanjing Xingong Industrial Investment and Huatai Trust Fund, a subsidiary of Huatai Zijin. Wenzhou Investment continued to follow up, and Kyushu Ventures and other institutions followed.
This article is reproduced from: https://www.itjuzi.com/investevent/13334291
This site is for inclusion only, and the copyright belongs to the original author.